Cancer Biology & Medicine

Papers
(The H4-Index of Cancer Biology & Medicine is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity197
Eliminating cervical cancer: a global health imperative for women107
Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up67
Early-onset gastric cancer global burden profile, trends, and contributors60
Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance54
Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy49
The Warburg effect drives dedifferentiation through epigenetic reprogramming45
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer45
Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical cente45
Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies43
ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment40
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer38
Biological mechanism and immune response of MHC-II expression in tumor cells37
Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival35
Chinese Society of Clinical Oncology Non-small Cell Lung Cancer (CSCO NSCLC) guidelines in 2024: key update on the management of early and locally advanced NSCLC32
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis28
Cancer stem cells: a target for overcoming therapeutic resistance and relapse27
Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis27
Immune checkpoint inhibitors: breakthroughs in cancer treatment26
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity25
Advances in lung cancer screening and early detection25
Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier24
Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a22
Human papillomavirus vaccination willingness under resource inequities: momentary intervention effects of an educational video22
Nodal peripheral T-cell lymphomas in the new classification systems22
0.15992021560669